Amgen Inc.
AMGN
$270.01
-$2.04-0.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 16.32% | 19.01% | 21.51% | 16.68% | 13.11% |
| Total Other Revenue | -0.37% | 9.22% | 15.53% | 10.28% | 5.97% |
| Total Revenue | 15.56% | 18.57% | 21.25% | 16.37% | 12.76% |
| Cost of Revenue | 14.93% | 25.27% | 62.42% | 45.68% | 30.72% |
| Gross Profit | 15.81% | 16.00% | 6.47% | 6.16% | 6.75% |
| SG&A Expenses | 11.74% | 24.67% | 27.90% | 24.43% | 14.66% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 1.29% | 38.98% | -171.17% | -72.41% | -74.63% |
| Total Operating Expenses | 15.23% | 25.01% | 30.50% | 30.06% | 16.88% |
| Operating Income | 16.24% | 6.47% | 2.09% | -8.16% | 4.95% |
| Income Before Tax | 53.05% | -41.32% | -46.53% | -61.67% | -52.32% |
| Income Tax Expenses | 23.20% | -54.39% | -62.11% | -67.54% | -51.34% |
| Earnings from Continuing Operations | 57.67% | -39.11% | -44.09% | -60.77% | -52.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 57.67% | -39.11% | -44.09% | -60.77% | -52.47% |
| EBIT | 16.24% | 6.47% | 2.09% | -8.16% | 4.95% |
| EBITDA | 18.53% | 15.90% | 16.34% | 4.70% | 11.20% |
| EPS Basic | 56.99% | -39.39% | -44.30% | -60.83% | -52.50% |
| Normalized Basic EPS | 29.33% | 9.64% | -12.72% | -16.65% | -19.77% |
| EPS Diluted | 56.45% | -39.60% | -44.44% | -60.78% | -52.37% |
| Normalized Diluted EPS | 29.00% | 9.59% | -12.79% | -16.64% | -19.74% |
| Average Basic Shares Outstanding | 0.37% | 0.37% | 0.28% | 0.19% | 0.09% |
| Average Diluted Shares Outstanding | 0.70% | 0.37% | 0.33% | 0.14% | -0.05% |
| Dividend Per Share | 5.67% | 5.63% | 6.60% | 7.62% | 8.68% |
| Payout Ratio | -0.33% | 0.74% | 0.91% | 1.75% | 1.29% |